References
- Zhu Y, Fu J, Yang H, et al. Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia. Respir Res. 2015;16(1):75.
- Chess PR, D'Angio CT, Pryhuber GS, et al. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):171–178.
- Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123(6):1562–1573.
- Zhao S, Cao M, Wu H, et al. 5-aza-2'-deoxycytidine inhibits the proliferation of lung fibroblasts in neonatal rats exposed to Hyperoxia. Pediatr Neonatol. 2017;58(2):122–127.
- Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36(3):131–149.
- Johannessen LE, Knardal SL, Madshus IH. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein. Biochem J. 1999;337(3):599–606.
- Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005;65(10):3980–3985.
- Londhe VA, Sundar IK, Lopez B, et al. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung. Pediatr Res. 2011;69(5 Part 1):371–377.
- Rodriguez R, Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol Biol Cell. 2006;17(1):402–412.
- Kang KA, Zhang R, Kim GY, et al. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumor Biol. 2012;33(2):403–412.
- Fainaru O, Shseyov D, Hantisteanu S, et al. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci U S A. 2005;102(30):10598–10603.
- Fainaru O, Woolf E, Lotem J, et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. Embo J. 2004;23(4):969–979.
- Meng S, Cao J, Zhang X, et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One. 2013;8(7):e68611.
- Wagenaar GTM, ter Horst SAJ, van Gastelen MA, et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med. 2004;36(6):782–801.
- You K, Xu X, Fu J, et al. Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1. Respir Res. 2012;13:36.
- Matute-Bello G, Downey G, Moore BB, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44(5):725–738.
- Shan Y, Cao W, Wang T, et al. ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling. Cancer Manag Res. 2017;9:879–889.
- Suenaga K, Takasawa H, Watanabe T, et al. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis. Mutat Res. 2013;751(1):73–83.
- Sammour I, Somashekar S, Huang J, et al. The effect of Gender on Mesenchymal Stem Cell (MSC) efficacy in neonatal hyperoxia-induced lung injury. PLoS One. 2016;11(10):e0164269.
- Jilling T, Ren C, Yee A, et al. Exposure of neonatal mice to bromine impairs their alveolar development and lung function. Am J Physiol Lung Cell Mol Physiol. 2018;314(1):L137–L143.
- Chen C-M, Lin W, Huang L-T, Chou H-C. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Am J Transl Res. 2017;8(47):342–353.
- Staversky RJ, Watkins RH, Wright TW, et al. Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am J Pathol. 2002;161(4):1383–1393.
- Condorelli G, Aycock JK, Frati G, et al. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J. 2001;15(12):2162–2170.
- O'Reilly MA, Staversky RJ, Watkins RH, et al. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol. 2001;24(6):703–710.
- Santos S, Peinado VI, Ramírez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19(4):632–638.